Long-Term Treatment of Collagenous Colitis With Budesonide

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The aim of the trial is to examine the effect of budesonide treatment on collagenous colitis. All patients is treated for 6 weeks with budesonide and thereafter randomised to 24 weeks treatment with placebo or continued budesonide. The end poit is effect on clinical symptoms (number of daily stools)
Epistemonikos ID: b87e63684ce06ee11840987c560561e413d7946e
First added on: May 04, 2024